WebPACLITAXEL ACCORD Paclitaxel Concentrated Injection 30 mg/5 mL, 100 mg/16.7 mL and 300 mg/50 mL Consumer Medicine Information PACLITAXEL ACCORD Published by MIMS February 2024 1 What is in this leaflet This leaflet answers some common questions about Paclitaxel Accord. It does not contain all the available information. It does not … WebPACLITAXEL ACCORD Paclitaxel Concentrated Injection 30 mg/5 mL, 100 mg/16.7 mL and 300 mg/50 mL Consumer Medicine Information PACLITAXEL ACCORD Published …
Paclitaxel – Accord Farma – Empresa Biofarmacêutica
WebOct 16, 2013 · Increased Survival in Pancreatic Cancer n engl j med 369;18 nejm.org31, october 2013 1693 matologic, hepatic, and renal function (including an absolute neutrophil count of ≥1.5×10 9 per liter ... Webauthorisation for Paclitaxel Accord 6 mg/ml, concentrate for solution for intravenous infusion from Accord Healthcare B.V. The date of authorisation was on 31 August 2010 in the Netherlands. The product is indicated for: • Ovarian carcinoma In the first-line chemotherapy of ovarian cancer for patients with advanced carcinoma of the ovary or lord richard harrington mp
paclitaxel injection, USP Dosage and Administration
WebMar 20, 2024 · Docetaxel Accord is used with cisplatin and fluorouracil (other cancer medicines); head and neck cancer in patients whose cancer is locally advanced (a cancer that has grown but has not spread). Docetaxel Accord is used with cisplatin and fluorouracil. Docetaxel Accord is a ‘ generic medicine ’. WebProduct and Consumer Medicine Information. PI & CMI Trade Names and Active Ingredients containing paclitaxel. 5 Documents available. Trade Name. Information Sheet. Active Ingredient (s) ABRAXANE. CMI PI. Paclitaxel; paclitaxel. Anzatax Injection. WebWhat it is used for. - Primary treatment of ovarian cancer in combination with a platinum agent. - Treatment of metastatic carcinoma of the ovary after failure of standard … lord richard margesson